Heart failure drug gets extended safety check in 800 patients
Disease control
ENROLLING_BY_INVITATION
This study provides continued access to an experimental oral medication called levosimendan (TNX-103) for people with pulmonary hypertension linked to a specific type of heart failure. It aims to monitor the long-term safety of the drug in 800 participants who have already taken …
Phase: PHASE3 • Sponsor: Tenax Therapeutics, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC